The serum concentration of Rosuvastatin can be increased when it is combined with Prednisolone. The serum concentration of Rosuvastatin can be increased when it is combined with Argatroban. The risk or severity of adverse effects can be increased when Ezetimibe is combined with Atorvastatin. The risk or severity of adverse effects can be increased when Efonidipine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Thiorphan. The risk or severity of adverse effects can be increased when Niludipine is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Nicotinamide is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Epigallocatechin Gallate. The serum concentration of Rosuvastatin can be increased when it is combined with Clotiazepam. Gemfibrozil may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Azithromycin. The risk or severity of adverse effects can be increased when Methysergide is combined with Ezetimibe. The serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium Hydroxide. The risk or severity of adverse effects can be increased when Lysergic Acid Diethylamide is combined with Rosuvastatin. The serum concentration of Bosutinib can be increased when it is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be decreased when it is combined with Bismuth Subcitrate. The serum concentration of Rosuvastatin can be increased when it is combined with Josamycin. The risk or severity of adverse effects can be increased when Gabapentin is combined with Rosuvastatin. The risk or severity of adverse effects can be increased when Methysergide is combined with Rosuvastatin. Acipimox may increase the myopathic rhabdomyolysis activities of Rosuvastatin. The risk or severity of adverse effects can be increased when Oxiconazole is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Vinorelbine. The serum concentration of Rosuvastatin can be increased when it is combined with Rutin. The serum concentration of Rosuvastatin can be increased when it is combined with Aldesleukin. The serum concentration of Rosuvastatin can be increased when it is combined with Paclitaxel. The serum concentration of Rosuvastatin can be increased when it is combined with Risperidone. The serum concentration of Rosuvastatin can be increased when it is combined with Topotecan. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Ezetimibe. The metabolism of Rosuvastatin can be decreased when combined with Topiroxostat. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Rosuvastatin. Rosuvastatin may increase the anticoagulant activities of Phenindione. The serum concentration of Rosuvastatin can be increased when it is combined with Pravastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Dalfopristin. The serum concentration of Cerivastatin can be increased when it is combined with Ezetimibe. The serum concentration of Rosuvastatin can be increased when it is combined with Dimethyl sulfoxide. The metabolism of Rosuvastatin can be decreased when combined with Chloramphenicol. The serum concentration of Rosuvastatin can be increased when it is combined with Lopinavir. The serum concentration of Rosuvastatin can be increased when it is combined with Clomifene. The serum concentration of Rosuvastatin can be increased when it is combined with Progesterone. The serum concentration of Rosuvastatin can be increased when it is combined with Faldaprevir. The risk or severity of adverse effects can be increased when Rosuvastatin is combined with Mecamylamine. The metabolism of Rosuvastatin can be decreased when combined with Trimethoprim. The serum concentration of Rosuvastatin can be increased when it is combined with Repaglinide. The serum concentration of Rosuvastatin can be increased when it is combined with Saquinavir. The serum concentration of Rosuvastatin can be increased when it is combined with Cerivastatin. Rosuvastatin may increase the anticoagulant activities of Ethyl biscoumacetate. The serum concentration of Rosuvastatin can be increased when it is combined with Tetracycline. The metabolism of Rosuvastatin can be decreased when combined with Nicardipine. The serum concentration of Rosuvastatin can be increased when it is combined with Metronidazole. The serum concentration of Rosuvastatin can be increased when it is combined with Trandolapril. The serum concentration of Rosuvastatin can be increased when it is combined with Ifosfamide. The serum concentration of Rosuvastatin can be increased when it is combined with Lisinopril. The serum concentration of Rosuvastatin can be increased when it is combined with Quinidine. The serum concentration of Rosuvastatin can be increased when it is combined with Lapatinib. The metabolism of Rosuvastatin can be decreased when combined with Zucapsaicin. The serum concentration of Rosuvastatin can be increased when it is combined with Regorafenib. The serum concentration of Rosuvastatin can be decreased when it is combined with Deferasirox. The metabolism of Rosuvastatin can be decreased when combined with Valsartan. The serum concentration of Rosuvastatin can be decreased when it is combined with Aluminum hydroxide. The serum concentration of Rosuvastatin can be increased when it is combined with Letaxaban. The serum concentration of Rosuvastatin can be increased when it is combined with Caffeine. The serum concentration of Rosuvastatin can be increased when it is combined with Nitric Oxide. The serum concentration of Rosuvastatin can be decreased when it is combined with Almasilate. The serum concentration of Rosuvastatin can be increased when it is combined with Aprotinin. The metabolism of Rosuvastatin can be decreased when combined with Losartan. The metabolism of Rosuvastatin can be increased when combined with St. John's Wort. The metabolism of Rosuvastatin can be decreased when combined with Irbesartan. The serum concentration of Rosuvastatin can be increased when it is combined with Geldanamycin. The risk or severity of adverse effects can be increased when Naftopidil is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Darunavir. The serum concentration of Rosuvastatin can be increased when it is combined with Nitrendipine. The serum concentration of Rosuvastatin can be increased when it is combined with Glyburide. The serum concentration of Rosuvastatin can be increased when it is combined with Simvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Mitoxantrone. The metabolism of Rosuvastatin can be decreased when combined with Delavirdine. The serum concentration of Rosuvastatin can be increased when it is combined with Ivacaftor. The serum concentration of Tolvaptan can be increased when it is combined with Ezetimibe. The serum concentration of Rosuvastatin can be increased when it is combined with Mefloquine. The serum concentration of Rosuvastatin can be increased when it is combined with Lansoprazole. The metabolism of Rosuvastatin can be decreased when combined with Posaconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Itraconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Antipyrine. The serum concentration of Rosuvastatin can be increased when it is combined with Benazepril. The serum concentration of Rosuvastatin can be increased when it is combined with Ergoloid mesylate. The metabolism of Rosuvastatin can be decreased when combined with Sulfamethoxazole. The serum concentration of Rosuvastatin can be decreased when it is combined with Magnesium Trisilicate. The metabolism of Rosuvastatin can be decreased when combined with Cholecalciferol. The serum concentration of Rosuvastatin can be increased when it is combined with Raloxifene. The metabolism of Rosuvastatin can be decreased when combined with Ticlopidine. The serum concentration of Rosuvastatin can be increased when it is combined with GM6001. The metabolism of Rosuvastatin can be decreased when combined with Imatinib. The serum concentration of Rosuvastatin can be increased when it is combined with Troleandomycin. The metabolism of Rosuvastatin can be decreased when combined with Tolbutamide. The serum concentration of Rosuvastatin can be increased when it is combined with Cyproterone acetate. The serum concentration of Rosuvastatin can be increased when it is combined with Betamethasone. The metabolism of Rosuvastatin can be decreased when combined with Fluconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Felodipine. The risk or severity of adverse effects can be increased when Vinpocetine is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Saxagliptin. The serum concentration of Rosuvastatin can be increased when it is combined with Norfloxacin. The serum concentration of Rosuvastatin can be increased when it is combined with Levosalbutamol. The metabolism of Rosuvastatin can be decreased when combined with Fluoxetine. Rosuvastatin may increase the anticoagulant activities of Warfarin. The metabolism of Rosuvastatin can be decreased when combined with Idelalisib. The serum concentration of Rosuvastatin can be increased when it is combined with Methylergometrine. The serum concentration of Rilpivirine can be increased when it is combined with Ezetimibe. The metabolism of Rosuvastatin can be decreased when combined with Rucaparib. The serum concentration of Rosuvastatin can be increased when it is combined with Darexaban. The serum concentration of Rosuvastatin can be increased when it is combined with Prinomastat. The serum concentration of Rosuvastatin can be increased when it is combined with Mequitazine. The metabolism of Rosuvastatin can be decreased when combined with Bortezomib. The serum concentration of Rosuvastatin can be increased when it is combined with Edoxaban. The serum concentration of Rosuvastatin can be increased when it is combined with Methazolamide. The serum concentration of Rosuvastatin can be increased when it is combined with Caspofungin. The serum concentration of Rosuvastatin can be increased when it is combined with Danazol. The metabolism of Rosuvastatin can be decreased when combined with Fluvastatin. The serum concentration of Ezetimibe can be increased when it is combined with Rolapitant. The serum concentration of Rosuvastatin can be increased when it is combined with Hydralazine. The serum concentration of Ezetimibe can be decreased when it is combined with Lumacaftor. The serum concentration of Ezetimibe can be increased when it is combined with Eltrombopag. The serum concentration of Rosuvastatin can be increased when it is combined with Buprenorphine. The risk or severity of adverse effects can be increased when Fenofibrate is combined with Rosuvastatin. The serum concentration of Rosuvastatin can be increased when it is combined with Ombitasvir. The serum concentration of Rosuvastatin can be increased when it is combined with Ezetimibe. The serum concentration of Rosuvastatin can be increased when it is combined with Dexamethasone. The serum concentration of Rosuvastatin can be increased when it is combined with Clopidogrel. The serum concentration of Rosuvastatin can be increased when it is combined with Bifonazole. The serum concentration of Rosuvastatin can be increased when it is combined with Cisapride. The serum concentration of Rosuvastatin can be increased when it is combined with Miconazole. The serum concentration of Rosuvastatin can be increased when it is combined with Dextropropoxyphene.